FEATURE COMPANY

PSYCHEDELIC NEWS

Last

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

ALERT COVID-19 | Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3

SNC-Lavalin Reports Second Quarter 2020 Results

Air Canada Reports Second Quarter 2020 Results

Shopify Announces Second-Quarter 2020 Financial Results

Datametrex Awarded $208,800 Milestone 3 Completion Payment from Canada’s Defence Innovation Program

UPDATE : The company denies this news release. Danbury Resources (DNR) Announces it’s Evaluating Acquisition Proposal at $1.2 a Share

Datametrex Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

Graph Blockchain Provides Update on Launch of BluStem Ecommerce Wellness Platform

StageZero Life Sciences Provides an Update on Testing for COVID-19 In the USA.

Graph Blockchain Announces Non-Binding LOI to Procure PPE Products like EN14126 + Type 4 Level C/D Protective Clothing, hand sanitizers, and N95 /KF94 masks

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

ImmunoPrecise Provides Updates on B Cell Select™ and Deep Display™ Programs for SARS-CoV-2 Antibody Discovery

FluroTech Partners With Albany Medical College For the Potential Development of a COVID-19 Diagnostic Test

PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

Relevium Reports $250,000 in Pre-Sales for Bioganix® CleanCare Hand Sanitizers in First 6 Days

ImmunoPrecise Participates in Public Consensus Statement, from the WHO, on Collaboration for Developing a COVID-19 Vaccine

Generex Biotechnology Provides Update on the Development of an Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic

UPDATE – BriaCell Files Coronavirus Immunotherapy Patent

VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT

SANUWAVE Health Announces Successful Filing of Patent for Use of Shockwaves to Treat Respiratory Ailments, Including Viral Infections Such as COVID-19

RELEVIUM LAUNCHES PRE-ORDER OF BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA AND USA

Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases

VitalHub Announces Deployment of COVID-19 Electronic Screening Tool for Long Term Care

Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial

Ridgestone Drills Into Sulphide-Rich Zones To Depths Of 170 Meters At Rebeico

Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies

DECN Receives Pre-EUA Acknowledgement Letter And Product Serial Number From U.S. FDA For GenViro!(TM) Covid-19 Screening Kit For Professional Use

Unique Fabricating Modifies Production Capabilities to Manufacture Protective Face Shields for Frontline Healthcare Workers and First Responders Amidst COVID-19 Pandemic

DECN Files Finalized FDA EUA Application for Its Genviro! Covid-19 Swift Kit, Receives Notification of Acceptance From FDA After-Hours on Friday 4/3/2020

Aytu BioScience Announces First Commercial Shipment of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test

Revive Therapeutics Announces Filing of FDA Pre-IND Meeting

RELEVIUM TO COMMERCIALIZE BIOGANIX® CLEANCARE HAND SANITIZERS

FDA Approves Emergency IND Use of Humanigen’s Lenzilumab For Compassionate Use In COVID-19 Patients

Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19

Talisker Intersects 27.3 g/t Au over 0.6 m in First Drill Hole at Bralorne Gold Project

Bonterra Intersects 7.35 Grams Per Tonne Au Over 8.35 Metres at Barry

RJK Explorations Discovers 18 Diamonds from a 22.4 kg (50 lb) Core Sample

Aytu BioScience Announces Receipt of Initial Shipment of 100,000 COVID-19 IgG/IgM Point-of-Care Rapid Tests; Additional 500,000 Tests on Order

G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

AirBoss Announces US$96 Million Contract for FlexAir™ PAPR System from FEMA to Help Battle COVID-19

StageZero Life Sciences preparing to offer COVID-19 testing in the U.S. and Canada

Sona partners with GE Healthcare Life Sciences to complete Coronavirus Rapid Screening Test

Innodata Successfully Implements Business Continuity Plan; Commits to Serving Medical Community for Data Analytics for COVID-19 Emergency

Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs

ABBOTT LAUNCHES MOLECULAR POINT-OF-CARE TEST TO DETECT NOVEL CORONAVIRUS IN AS LITTLE AS FIVE MINUTES

Natural Cycles Launches COVID-19 Symptom Trackers In-App

VAXIL COMMENCES PRECLINICAL COVID-19 VACCINE TRIAL AND FILES AN ADDITIONAL COVID-19 PATENT

WELL Health Announces Automated Phone, SMS and Web-based COVID-19 Triage Tool for Canadians

Hydromer Inc. Now Active in the COVID-19 Emergency Response with Availability of its Sanitizers and Antimicrobial Coatings

AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Exclusive Advisory Agreement Signed for COVID-19 and Host Cell Interactions

DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White House – Call to Action” to Analyse and Transform COVID-19 Data into Clinical Knowledge

Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-19 Testing

Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program

T2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health’s Center for Discovery and Innovation

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19

Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant

Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19

Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Anything Technologies Media, Inc.’s Subsidiary, Sonoran Flower, Announces New Anti-Microbial, Anti-Bacterial Product IMMUNE PLUS Spray to Help Protect Against Deadly Viruses like the Coronavirus, SARS, and Others

No Borders, Inc. (Ticker:NBDR) Subsidiary MediDent Supplies Announces New Stay At Home 15 Minute COVID-19 Blood Tests

DECN Finalizes FDA Pre-EUA Version of Its Genviro! Screening Covid-19 Swift Kit, Providing Results in 15 Seconds Using Only 1.0-2.0 Microliters Whole Blood

Corona Virus COVID-19 Hits Home Worldwide as GlobeX Data’s Secure Cloud Communications Services Demand Soars

ABMC Offers Rapid Test for Covid-19

Covid-19 Treatment Provisional Patent Application Filed; Premier Biomedical, Inc. Granted Global Commercial Rights

Waitr Partners with Ralph’s Market to Expand into Grocery Delivery

Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials

Liminal BioSciences comments on Coronavirus (COVID-19)

Blockchain Holdings to Acquire COVID-19 Quarantine Management Product TRACEsafe

Algernon to Support Planned Phase 2 Trial of Ifenprodil for Coronavirus

Revive Therapeutics Explores the Use of Bucillamine as a Novel Treatment for Infectious Diseases including COVID-19

Humanigen Planning Phase III Study of Coronavirus Treatment

DECN to Finance 2Q 2020 Roll Out of its GenViro! Covid-19 “Rapid” Kits Using

Carbon Health Announces Immediate Availability of First COVID-19 Home Test Kits

Bacardi Helps Produce Hand Sanitizers With Change in Production

Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Nascent Biotech has Begun In Vitro Studies as a Potential Therapeutic Agent Against COVID-19

ParcelPal Increases Operations for Covid-19

Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and Mexico

NexTech AR Reports Boost in Demand for its Products as Coronavirus Drives Shopping From Home

QIAGEN Dramatically Ramping Up Global Production Capacity for RNA Extraction Kits for Use in Detection of SARS-CoV-2 Coronavirus

FDA Policy Change to Allow Rapid Domestic Expansion of Co-Diagnostics COVID-19 Test

Alimentation Couche-Tard Announces its Results for its Q3 2020

NetCents Technology Projects Acceleration of Contactless Payments on the Heels of World Health Organization Endorsement

Air Canada Provides Update on Response to COVID-19

Vaxil Provides Update Website, Lab Work and the Exercise of Warrants

NetCents Technology Targets New Revenue Stream

VitalHub Announces Patient Flow Solution to Address Needs of COVID-19 Pandemic

Roadman Investments Enters Into Letter of Intent to Acquire PanAsia Distribution Corp.

Nexera Energy (Formerly Emerald Bay) Confirms Name Change/Consolidation

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use

Bombardier Announces Leadership Change